Total Payments
$100,155
2024 Payments
$26,100
Companies
10
Transactions
72
Medicare Patients
2,083
Medicare Billing
$484,938
Payment Breakdown by Category
Other$64,975 (64.9%)
Travel$33,183 (33.1%)
Food & Beverage$1,397 (1.4%)
Consulting$600.00 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $47,925 | 18 | 47.9% |
| Travel and Lodging | $33,183 | 21 | 33.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,050 | 5 | 17.0% |
| Food and Beverage | $1,397 | 27 | 1.4% |
| Consulting Fee | $600.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| bioMerieux Inc | $95,547 | 51 | $0 (2024) |
| Fisher Scientific Company L.L.C. | $2,575 | 2 | $0 (2024) |
| La Jolla Pharmaceutical Company | $1,456 | 3 | $0 (2018) |
| ExThera Medical Corporation | $137.83 | 2 | $0 (2023) |
| United Therapeutics Corporation | $126.86 | 2 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $84.58 | 4 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $82.71 | 5 | $0 (2021) |
| Insmed, Inc. | $74.16 | 1 | $0 (2023) |
| Astute Medical, Inc. | $53.87 | 1 | $0 (2017) |
| Theravance Biopharma Inc. | $16.67 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,100 | 17 | bioMerieux Inc ($23,525) |
| 2023 | $9,146 | 5 | bioMerieux Inc ($8,954) |
| 2021 | $671.46 | 5 | bioMerieux Inc ($600.00) |
| 2020 | $12,699 | 9 | bioMerieux ($12,682) |
| 2019 | $7,734 | 7 | bioMerieux ($7,720) |
| 2018 | $1,456 | 3 | La Jolla Pharmaceutical Company ($1,456) |
| 2017 | $42,347 | 26 | bioMerieux ($42,065) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Honoraria | In-kind items and services | $2,500.00 | General |
| Category: Infectious Disease | ||||||
| 11/27/2024 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Food and Beverage | In-kind items and services | $75.04 | General |
| Category: Infectious Disease | ||||||
| 08/09/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Diagnostics | ||||||
| 08/09/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Travel and Lodging | Cash or cash equivalent | $2,624.00 | General |
| Category: Diagnostics | ||||||
| 08/09/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Travel and Lodging | Cash or cash equivalent | $624.00 | General |
| Category: Diagnostics | ||||||
| 08/09/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Travel and Lodging | Cash or cash equivalent | $308.19 | General |
| Category: Diagnostics | ||||||
| 08/09/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Travel and Lodging | Cash or cash equivalent | $251.50 | General |
| Category: Diagnostics | ||||||
| 08/09/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Travel and Lodging | Cash or cash equivalent | $110.72 | General |
| Category: Diagnostics | ||||||
| 08/09/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: Diagnostics | ||||||
| 07/31/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Travel and Lodging | Cash or cash equivalent | $5,904.00 | General |
| Category: Diagnostics | ||||||
| 07/31/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Diagnostics | ||||||
| 07/31/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Diagnostics | ||||||
| 07/31/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Travel and Lodging | Cash or cash equivalent | $1,083.96 | General |
| Category: Diagnostics | ||||||
| 07/31/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Travel and Lodging | Cash or cash equivalent | $169.86 | General |
| Category: Diagnostics | ||||||
| 07/31/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Travel and Lodging | Cash or cash equivalent | $144.83 | General |
| Category: Diagnostics | ||||||
| 07/31/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Travel and Lodging | Cash or cash equivalent | $37.52 | General |
| Category: Diagnostics | ||||||
| 07/17/2024 | bioMerieux Inc | VIDAS NEPHROCHECK (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Diagnostics | ||||||
| 09/29/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $74.16 | General |
| Category: Respiratory | ||||||
| 01/22/2023 | bioMerieux Inc | FILMARRAY PNEUMONIA PANEL (PNEUMO) (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: Diagnostics | ||||||
| 01/22/2023 | bioMerieux Inc | FILMARRAY PNEUMONIA PANEL (PNEUMO) (Device) | Travel and Lodging | Cash or cash equivalent | $4,065.85 | General |
| Category: Diagnostics | ||||||
| 01/22/2023 | ExThera Medical Corporation | — | Food and Beverage | Cash or cash equivalent | $117.73 | General |
| 01/22/2023 | bioMerieux Inc | — | Food and Beverage | In-kind items and services | $88.62 | General |
| 08/31/2021 | bioMerieux Inc | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 08/19/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 531 | 942 | $354,087 | $113,188 |
| 2022 | 9 | 543 | 1,103 | $402,152 | $131,243 |
| 2021 | 7 | 458 | 894 | $332,598 | $108,910 |
| 2020 | 7 | 551 | 982 | $399,351 | $131,597 |
Total Patients
2,083
Total Services
3,921
Medicare Billing
$484,938
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 166 | 420 | $223,824 | $71,535 | 32.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 120 | 233 | $65,139 | $22,085 | 33.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 66 | $28,668 | $8,964 | 31.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 76 | 113 | $21,631 | $7,105 | 32.8% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 19 | 23 | $9,959 | $1,972 | 19.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 16 | 16 | $3,078 | $979.73 | 31.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 22 | 22 | $660.00 | $204.38 | 31.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 22 | 22 | $506.00 | $152.46 | 30.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 16 | 16 | $336.00 | $102.40 | 30.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 11 | 11 | $286.00 | $87.78 | 30.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 156 | 425 | $236,064 | $76,548 | 32.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 153 | 364 | $90,728 | $30,139 | 33.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 74 | $36,002 | $12,156 | 33.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 89 | 150 | $26,586 | $8,589 | 32.3% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $7,650 | $2,344 | 30.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 18 | 19 | $3,420 | $1,016 | 29.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 19 | 19 | $570.00 | $182.48 | 32.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 17 | 17 | $718.00 | $140.01 | 19.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 18 | 18 | $414.00 | $129.12 | 31.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 151 | 325 | $182,282 | $59,614 | 32.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 137 | 315 | $80,409 | $27,325 | 34.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 75 | 150 | $26,269 | $8,805 | 33.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 46 | 50 | $25,105 | $7,984 | 31.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 17 | 17 | $7,801 | $2,484 | 31.8% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 14 | 16 | $6,928 | $1,487 | 21.5% |
About Dr. Devendra Amin, M.D
Dr. Devendra Amin, M.D is a Critical Care Medicine healthcare provider based in Clearwater, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508847070.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devendra Amin, M.D has received a total of $100,155 in payments from pharmaceutical and medical device companies, with $26,100 received in 2024. These payments were reported across 72 transactions from 10 companies. The most common payment nature is "Honoraria" ($47,925).
As a Medicare-enrolled provider, Amin has provided services to 2,083 Medicare beneficiaries, totaling 3,921 services with total Medicare billing of $484,938. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Clearwater, FL
- Active Since 11/10/2005
- Last Updated 07/21/2022
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1508847070
Products in Payments
- Procalcitonin (Device) $42,947
- VIDAS NEPHROCHECK (Device) $23,525
- VIDAS BRAHMS PCT (Device) $20,182
- FILMARRAY PNEUMONIA PANEL (PNEUMO) (Device) $8,866
- GIAPREZA (Drug) $1,326
- ORENITRAM (Drug) $126.86
- XARELTO (Drug) $82.71
- Arikayce (Drug) $74.16
- PRALUENT (Drug) $68.36
- NephroCheck Test (Device) $53.87
- Seraph 100 Microbind Affinity Filter (Device) $20.10
- NEPHROCHECK TEST (Device) $18.00
- VIBATIV (Drug) $16.67
- MULTAQ (Drug) $16.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Clearwater
Dr. Jeramy Mosburg, D.o, D.O
Critical Care Medicine — Payments: $2,930
Critical Care Medicine $2,930
Melanie Cheing, M.d, M.D
Critical Care Medicine — Payments: $1,187
Critical Care Medicine $1,187
Shana Sobie, Rn, RN
Critical Care Medicine — Payments: $957.92
Critical Care Medicine $957.92
Dr. Janet Roman, Aprn, APRN
Critical Care Medicine — Payments: $672.18
Critical Care Medicine $672.18
Ms. Melody Hardway, Rn-Anp, RN-ANP
Critical Care Medicine — Payments: $374.86
Critical Care Medicine $374.86
Theresa Buck, M.d, M.D
Critical Care Medicine — Payments: $118.64
Critical Care Medicine $118.64